Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Total return indices include income from dividends, offering a fuller performance picture. Use them to analyze long-term trends and benchmark returns.
22,064 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Bond yields climbed this week, increasing borrowing costs for homebuyers and businesses while influencing stock marke...
NBCUniversal has reported a record-setting production cost for a 2022 blockbuster, surpassing Disney’s previous budge...
Bitcoin pulled back from intraday highs as Iran's strikes in the Middle East sparked risk-off sentiment. the bitcoin ...
Early 2026 shows Asia-led gains outpacing the U.S., with Asia-focused ETFs rising as tech and earnings momentum impro...
Iran signals a selective pass-through policy at the Strait of Hormuz, potentially tightening oil flows and boosting m...
A veteran economist warns that the long-standing cushion for markets is thinning. AI-driven gains mask growing vulner...
A chip-focused fund jumps roughly 80% in 2026, signaling investors are seeking broader exposure to AI infrastructure ...
Global container rates surge again amid geopolitical tension and tariff uncertainty, reviving concerns about another ...
The national debt sits just shy of $39 trillion, days before national debt crosses the milestone. Markets are watchin...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
A growing share of households are adopting financial minimalism as markets stay volatile in 2026. The approach favors...